Characterization of a Potent Neurogenic Compound

强效神经源性化合物的表征

• 批准号: 8374346
• 负责人: DAVID R SCHUBERT
• 金额: $ 28.8万
• 依托单位: SALK INSTITUTE FOR BIOLOGICAL STUDIES
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8374346
• 关键词: Adult; Age; Alzheimer' s Disease; Animals; Astrocytes; Behavioral; Biological Assay; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Culture Techniques; Cell Differentiation process; Cell Line; Cell Proliferation; Cell division; Cells; Commit; Data; Data Set; Development; Dominant-Negative Mutation; Fluoxetine; Glial Fibrillary Acidic Protein; Goals; Health; Hippocampus (Brain); Impaired cognition; In Vitro; Investigation; Label; Laboratory Study; Lead; Learning; Life; Memory; Memory impairment; Methods; Modeling; Molecular; Molecular Genetics; Mus; Nerve; Nerve Degeneration; Neuraxis; Neurodegenerative Disorders; Neuroglia; Neurons; Neuroprotective Agents; Neurotrophic Tyrosine Kinase Receptor Type 2; Oligodendroglia; Pathology; Pathway interactions; Pharmaceutical Preparations; Phenotype; Physiologic pulse; Play; Premature aging syndrome; Process; Production; Property; Proteins; Proteomics; Radiation; Rattus; Rodent; Role; Scheme; Screening procedure; Serotonin; Services; Signal Pathway; Staining method; Stains; Stem cells; Subfamily lentivirinae; Synapses; Technology; Testing; Therapeutic; Time; Transgenic Mice; Transgenic Organisms; Western Blotting; Work; adult neurogenesis; age related; aged; base; cell type; cognitive function; drug candidate; drug discovery; human embryonic stem cell; immunocytochemistry; improved; in vivo; molecular marker; nerve stem cell; nestin protein; neural precursor cell; neurogenesis; novel; precursor cell; prevent; research study; response; senescence; stem cell division; therapeutic target; uptake

DESCRIPTION (provided by applicant): Although neurogenesis occurs primarily during development, it is an active process that persists throughout life, and may play a role in normal learning and memory. Decreased levels of neurogenesis occur with age and perhaps in neurodegenerative conditions such as Alzheimer's disease (AD). Therefore, understanding the molecular basis of stem cell division and differentiation within the central nervous system (CNS) deserves thorough investigation. A novel drug discovery paradigm was used to select drug candidates for the treatment of neurodegenerative diseases that is based on efficacy in cell culture models of multiple, age-associated pathologies. This scheme has identified a potent, orally active compound, J147, which facilitates memory in normal rodents, prevents behavioral deficits and synaptic protein loss in AD transgenic mice, and reverses cognitive loss in aged transgenic AD mice. J147 is also neurogenic in mice, in adult rat hippocampal precursor cells in culture, and for human ESC-derived neural precursor cells. In addition, it has the unique ability of inhibiting the division of cells destined to be astrocytes. The overall aim in this study is to identify the type and fate of cells that respond to J147 in the mouse brain and to use this compound to better understand the molecular pathways involved in neurogenesis both in vivo and in cell culture models. Therefore the phenotype of the nerve-like cells made in response to J147 will be characterized both in animals and in a rat hippocampal precursor cell line that can produce either nerve or glia. Because the therapeutic potential of compounds like J147 in AD, it will be asked if J147 can induce neurogenesis in very old mice where other neurogenic compounds fail to act. Importantly, neurogenesis will be reduced by two independent methods and it will be asked if J147 is still able to enhance memory. Finally, a new proteomics approach will be used to identify the molecular signaling pathways responsible for J147-induced cell division and nerve differentiation. Results from this study may lead to a therapeutic application of J147 based upon manipulating neural stem cells to improve CNS health. PUBLIC HEALTH RELEVANCE: It is now generally recognized that new nerve cells continue to be produced in the adult brain, but there are currently very few ways to stimulate that process. We have recently made a very potent compound that can stimulate the production of new neurons in both young and old mice. The goal of this project is to better characterize the types of nerve cells that this compound generates and determine how it works.

描述（由申请人提供）：虽然神经发生主要发生在发育过程中，但它是一个持续一生的积极过程，可能在正常的学习和记忆中发挥作用。随着年龄的增长，神经发生水平下降，可能在神经退行性疾病，如阿尔茨海默病（AD）中发生。因此，了解中枢神经系统（CNS）内干细胞分裂和分化的分子基础值得深入研究。一种新的药物发现模式被用于选择治疗神经退行性疾病的候选药物，这是基于多种年龄相关病理的细胞培养模型的疗效。该方案已经确定了一种有效的口服活性化合物J147，它可以促进正常啮齿动物的记忆，防止AD转基因小鼠的行为缺陷和突触蛋白丢失，并逆转老年转基因AD小鼠的认知丧失。J147在小鼠、培养的成年大鼠海马前体细胞和人类esc来源的神经前体细胞中也具有神经源性。此外，它还具有独特的抑制星形胶质细胞分裂的能力。本研究的总体目标是确定小鼠大脑中对J147有反应的细胞的类型和命运，并利用这种化合物更好地了解体内和细胞培养模型中涉及神经发生的分子途径。因此，对J147产生的神经样细胞的表型将在动物和可以产生神经或胶质的大鼠海马前体细胞系中进行表征。因为像J147这样的化合物在阿尔茨海默病中的治疗潜力，人们会问J147是否能在其他神经源性化合物不起作用的高龄小鼠中诱导神经发生。重要的是，神经发生将通过两种独立的方法减少，并将询问J147是否仍然能够增强记忆。最后，一种新的蛋白质组学方法将用于鉴定j147诱导的细胞分裂和神经分化的分子信号通路。这项研究的结果可能导致基于操纵神经干细胞的J147的治疗应用，以改善中枢神经系统的健康。